Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease

Post author:
Post published:October 24, 2024
Post category:uncategorized

Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Pan-coronavirus vaccine shows success in mouse studies

Long-term benefits of weight-loss surgery in young people with severe obesity

Advanced microscopy reveals how ribosomes attach to mRNA for protein synthesis

Helpful Links

Subscribe To Us